STAND. COM. REP. NO. 1760-18

Honolulu, Hawaii

, 2018

RE: S.B. No. 2247

S.D. 1

H.D. 2

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

Sir:

Your Committee on Consumer Protection & Commerce, to which was referred S.B. No. 2247, S.D. 1, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO OPIOID ANTAGONISTS,"

begs leave to report as follows:

The purpose of this measure is to authorize pharmacists to prescribe and dispense opioid antagonists to:

(1) An individual who is at risk for an opioid overdose; or

(2) A family member or caregiver of an individual who is at risk of an opioid overdose,

regardless of whether the individual has evidence of a previous prescription for an opioid antagonist from a practitioner authorized to prescribe opioids and without the need for a written, approved collaborative agreement.

The Board of Pharmacy; Department of Health; University of Hawaii at Hilo Daniel K. Inouye College of Pharmacy; National Community Pharmacist Association – Hawaii Chapter; American Pharmacists Association – Academy of Student Pharmacists, Hawaii Chapter; Hawaii Medical Service Association; Hawaii Pharmacists Association; Kaiser Permanente Hawai‘i; Hawaii Substance Abuse Coalition; Oahu County Committee on Legislative Priorities of the Democratic Party of Hawai‘i; Walgreen Co; Drug Policy Forum of Hawaii; Life Foundation and the CHOW Project; Community Alliance on Prisons; Coalition for a Drug-Free Hawaii; The Salvation Army Addiction Treatment Services and Family Treatment Services; and many individuals testified in support of this measure. Hawaii Medical Service Association submitted comments.

Your Committee has amended this measure by:

(1) Inserting a sunset date of July 1, 2021; and

(2) Making technical, nonsubstantive amendments for clarity, consistency, and style.

As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2247, S.D. 1, H.D. 1, as amended herein, and recommends that it pass Third Reading in the form attached hereto as S.B. No. 2247, S.D. 1, H.D. 2.

Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,

____________________________

ROY M. TAKUMI, Chair